Clinical trial: Monoclonal antibody may be an effective alternative to cisplatin in treatment of head and neck cancers
Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report. Smokers and drinkers, as well as those with HPV infections, are disproportionately affected.
Nov 22, 2024
0
7